Medtronic FY27 Q1 GAAP diluted EPS rises 40.7% to $1.14; revenue climbs 13.7% to $9.8 billion - MDT News | RalliesMedtronic FY27 Q1 GAAP diluted EPS rises 40.7% to $1.14; revenue climbs 13.7% to $9.8 billion
M
MDT• Medtronic reports stronger Q1 FY27 results and raises outlook
- Medtronic Q1 FY27 revenue rose 13.7% to $9.76 billion; GAAP diluted EPS climbed to $1.14.
- GAAP net income attributable to shareholders increased 41.4% to $1.47 billion; GAAP operating profit grew 22.1% to $1.76 billion.
- Cardiovascular revenue increased 19.5% to $3.93 billion; Neuroscience rose 10.3% to $2.68 billion.
- Medical Surgical revenue climbed 10% to $2.28 billion; Diabetes increased 16.9% to $843 million.
- Raised FY27 organic revenue growth outlook to 7.25%-7.75%; lifted diluted non-GAAP EPS view to $5.94-$6.00.
TLT
•
